Dergi makalesi Açık Erişim
Farzani, Touraj Aligholipour; Foldes, Katalin; Hanifehnezhad, Alireza; Ilce, Burcu Yener; Dagalp, Seval Bilge; Khiabani, Neda Amirzadeh; Erguenay, Koray; Alkan, Feray; Karaoglu, Taner; Bodur, Hurrem; Ozkul, Aykut
{ "conceptrecid": "71640", "created": "2021-03-16T03:31:55.480802+00:00", "doi": "10.3390/v11030237", "files": [ { "bucket": "ff729624-c094-4034-bf2f-72a856ad88ac", "checksum": "md5:2f51262639c3e46fd1fc3f4256f1b743", "key": "bib-28100bf5-9e5b-4681-bbb4-e073de954a1d.txt", "links": { "self": "https://aperta.ulakbim.gov.tr/api/files/ff729624-c094-4034-bf2f-72a856ad88ac/bib-28100bf5-9e5b-4681-bbb4-e073de954a1d.txt" }, "size": 391, "type": "txt" } ], "id": 71641, "links": { "badge": "https://aperta.ulakbim.gov.tr/badge/doi/10.3390/v11030237.svg", "bucket": "https://aperta.ulakbim.gov.tr/api/files/ff729624-c094-4034-bf2f-72a856ad88ac", "doi": "https://doi.org/10.3390/v11030237", "html": "https://aperta.ulakbim.gov.tr/record/71641", "latest": "https://aperta.ulakbim.gov.tr/api/records/71641", "latest_html": "https://aperta.ulakbim.gov.tr/record/71641" }, "metadata": { "access_right": "open", "access_right_category": "success", "communities": [ { "id": "tubitak-destekli-proje-yayinlari" } ], "creators": [ { "affiliation": "Ankara Univ, Virol Dept, Fac Vet Med, TR-06110 Ankara, Turkey", "name": "Farzani, Touraj Aligholipour" }, { "affiliation": "Ankara Univ, Virol Dept, Fac Vet Med, TR-06110 Ankara, Turkey", "name": "Foldes, Katalin" }, { "affiliation": "Ankara Univ, Virol Dept, Fac Vet Med, TR-06110 Ankara, Turkey", "name": "Hanifehnezhad, Alireza" }, { "affiliation": "Ankara Univ, Biotechnol Inst, TR-06560 Ankara, Turkey", "name": "Ilce, Burcu Yener" }, { "affiliation": "Ankara Univ, Virol Dept, Fac Vet Med, TR-06110 Ankara, Turkey", "name": "Dagalp, Seval Bilge" }, { "affiliation": "Ankara Univ, Biotechnol Inst, TR-06560 Ankara, Turkey", "name": "Khiabani, Neda Amirzadeh" }, { "affiliation": "Hacettepe Univ, Dept Med Microbiol, Virol Unit, Fac Med, TR-06100 Ankara, Turkey", "name": "Erguenay, Koray" }, { "affiliation": "Ankara Univ, Virol Dept, Fac Vet Med, TR-06110 Ankara, Turkey", "name": "Alkan, Feray" }, { "affiliation": "Ankara Univ, Virol Dept, Fac Vet Med, TR-06110 Ankara, Turkey", "name": "Karaoglu, Taner" }, { "affiliation": "Saglik Bilimleri Univ, Numune Training & Res Hosp, Infect Dis Clin, TR-06100 Ankara, Turkey", "name": "Bodur, Hurrem" }, { "name": "Ozkul, Aykut" } ], "description": "Crimean-Congo hemorrhagic fever virus (CCHFV) is the causative agent of a tick-borne infection with a significant mortality rate of up to 40% in endemic areas, with evidence of geographical expansion. Due to a lack of effective therapeutics and control measures, the development of a protective CCHFV vaccine remains a crucial public health task. This paper describes, for the first time, a Bovine herpesvirus type 4 (BoHV-4)-based viral vector (BoHV4- increment TK-CCHFV-N) and its immunogenicity in BALB/c and protection potential in IFN alpha/beta/gamma R-/- mice models in comparison with two routinely used vaccine platforms, namely, Adenovirus type 5 and a DNA vector (pCDNA3.1 myc/His A), expressing the same antigen. All vaccine constructs successfully elicited significantly elevated cytokine levels and specific antibody responses in immunized BALB/c and IFN alpha/beta/gamma R-/- mice. However, despite highly specific antibody responses in both animal models, the antibodies produced were unable to neutralize the virus in vitro. In the challenge experiment, only the BoHV4- increment TK-CCHFV-N and Ad5-N constructs produced 100% protection against lethal doses of the CCHFV Ank-2 strain in IFN alpha/beta/gamma R-/- mice. The delivery platforms could not be compared due to similar protection rates in IFN alpha/beta/gamma R-/- mice. However, during the challenge experiment in the T cell and passive antibody transfer assay, BoHV4- increment TK-CCHFV-N was dominant, with a protection rate of 75% compared to others. In conclusion, vector-based CCHFV N protein expression constitutes an effective approach for vaccine development and BoHV-4 emerged as a strong alternative to previously used viral vectors.", "doi": "10.3390/v11030237", "has_grant": false, "journal": { "issue": "3", "title": "VIRUSES-BASEL", "volume": "11" }, "license": { "id": "cc-by" }, "publication_date": "2019-01-01", "relations": { "version": [ { "count": 1, "index": 0, "is_last": true, "last_child": { "pid_type": "recid", "pid_value": "71641" }, "parent": { "pid_type": "recid", "pid_value": "71640" } } ] }, "resource_type": { "subtype": "article", "title": "Dergi makalesi", "type": "publication" }, "title": "Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFN alpha/beta/gamma R-/- Mice Models" }, "owners": [ 1 ], "revision": 1, "stats": { "downloads": 6.0, "unique_downloads": 6.0, "unique_views": 46.0, "version_downloads": 6.0, "version_unique_downloads": 6.0, "version_unique_views": 46.0, "version_views": 47.0, "version_volume": 2346.0, "views": 47.0, "volume": 2346.0 }, "updated": "2021-03-16T03:31:55.524001+00:00" }
Görüntülenme | 47 |
İndirme | 6 |
Veri hacmi | 2.3 kB |
Tekil görüntülenme | 46 |
Tekil indirme | 6 |